Dimed SA Distribuidora do Medicamentos operates in the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Dimed SA Distribuidora do Medicamentos with three other
drug stores in Latin America:
Corporativo Fragua, SAB de CV
of MEXICO
(2018
sales of 53.35 billion Mexican Pesos [US$2.15 billion]
of which 70%
was Medical),
Raia Drogasil SA
(14.80 billion Brazilian Reals [US$2.90 billion]
of which 46%
was Drugs: Brand), and
Profarma Distribuidora de Produtos Farmaceuticos SA
(4.27 billion Brazilian Reals [US$837.65 million]
of which 91%
was Pharmaceutical Distribution).
Sales Analysis.
Dimed SA Distribuidora do Medicamentos reported sales of 2.43 billion Brazilian Reals (US$477.01 million)
for the
year ending
December of 2018.
This
represents
an
increase of 7.7%
versus 2017, when the company's sales were 2.26 billion Brazilian Reals.
Sales at Dimed SA Distribuidora do Medicamentos have increased during each of the previous five years
(and since 2013, sales have increased a total of 40%).
Sales of Retail saw an increase
of
9.7% in 2018, from
1.98 billion Brazilian Reals to 2.17 billion Brazilian Reals.
Not all segments of Dimed SA Distribuidora do Medicamentos experienced an increase in sales in 2018:
sales of Wholesale fell 2.2% to 257.86 million Brazilian Reals.